Results for the year ended 30 June 2026

Summary by AI ^BETAClose X

Beximco Pharma reported net revenue up 14.5% y/y to BDT 56,265.9m (£347.5m), with domestic sales +15.1% to BDT 51,852.5m and exports +8.3% to BDT 4,413.4m; profit after tax rose 30.9% to BDT 9,160.8m (£56.6m) and EPS increased to BDT 20.17 (2024-25: 15.56). The board recommends a 60% cash dividend (BDT 6.00/share). Cash and cash equivalents strengthened to BDT 6,668.0m (from BDT 1,700.1m) and operating cash flow was BDT 9,514.8m. Operationally the company launched Triko (generic Trikafta), Eletriptan in the US and Sotalol in Canada and completed multiple international registrations, supporting revenue momentum.

Disclaimer*

Companies

BEXIMCO PHARMACEUTICALS LIMITED (BXP)

UK 100

Latest directors dealings

2 hours ago Luceco
2 hours ago Helios Towers
3 hours ago Wise Class A
3 hours ago EDX Medical Group Plc
3 hours ago Naked Wines

All directors dealings today

	30 June 2026	Amount in Taka 30 June 2025
ASSETS

Property, plant and equipment	45,602,684,285	43,541,872,125
Right-of-use assets	359,772,325	485,613,049
Intangible assets	4,551,852,390	4,694,133,629
Deferred tax asset	19,651,021	44,078,388
Goodwill	674,570,185	674,570,185
Investment in associates	15,364,734	-
Other investments	6,733,457	20,974,134
Total non-current assets	51,230,628,397	49,461,241,510

Inventories	13,988,598,555	13,586,475,819
Spares and supplies	1,010,233,353	799,643,860
Trade and other receivables	3,669,562,137	3,628,788,364
Loans, advances, deposits and prepayments	3,220,129,543	2,814,492,520
Advance income tax	402,401,544	356,507,571
Short term investment	950,000,000	900,000,000
Cash and cash equivalents	6,668,012,479	1,700,096,960
Total current assets	29,908,937,611	23,786,005,094
TOTAL ASSETS	81,139,566,008	73,247,246,604

EQUITY AND LIABILITIES
Share capital	4,461,120,890	4,461,120,890
Share premium	5,269,474,690	5,269,474,690
Excess of issue price over face value of GDRs	1,689,636,958	1,689,636,958
Capital reserve on merger	294,950,950	294,950,950
Revaluation surplus	1,130,820,610	1,133,870,432
Unrealized gain/(loss)	3,908,281	18,148,958
Retained earnings	49,241,292,553	40,239,934,223
Total shareholders' equity	62,091,204,932	53,107,137,101
Non-controlling interest	4,103,149,348	3,977,498,766

TOTAL EQUITY	66,194,354,280	57,084,635,867

Long term borrowings-net of current maturity	1,738,988,035	1,503,595,560
Liability for gratuity and WPPF	3,395,313,958	3,688,238,284
Deferred tax liability	2,758,009,938	2,575,780,261
Non-current liabilities	7,892,311,931	7,767,614,105

Short term borrowings	2,303,467,001	2,025,393,637
Long term borrowings-current maturity	586,628,854	1,436,751,660
Trade and other payables	1,952,971,347	2,927,851,030
Accrued expenses	1,422,556,087	1,174,096,256
Dividend payable	137,953,976	302,271,608
Income tax payable	649,322,532	528,632,441
Total current liabilities	7,052,899,797	8,394,996,632
Total liabilities	14,945,211,728	16,162,610,737
TOTAL EQUITY AND LIABILITIES	81,139,566,008	73,247,246,604

		Amount in Taka

	30 June 2026	30 June 2025

Net revenue	56,265,856,224	49,120,354,035
Cost of goods sold	(28,870,192,837)	(26,825,860,744)
Gross profit	27,395,663,387	22,294,493,291

General and administrative expenses	(1,554,380,986)	(1,401,982,177)
Selling, marketing and distribution expenses	(13,395,060,921)	(11,044,794,908)
Operating expenses	(14,949,441,907)	(12,446,777,085)
Profit from operations	12,446,221,480	9,847,716,206

Other income	790,337,629	608,998,701
Finance cost	(656,352,588)	(991,706,942)
Share of profit of associates	15,364,734	-
Profit before tax and WPPF	12,595,571,255	9,465,007,965
Contribution to WPPF	(609,711,618)	(460,957,986)

Profit before tax	11,985,859,637	9,004,049,979
Current tax	(2,617,477,105)	(1,986,172,572)
Deferred tax	(207,542,476)	(19,007,698)
Income tax expenses	(2,825,019,581)	(2,005,180,270)
Profit after tax	9,160,840,056	6,998,869,709

Owners of the Company	8,997,423,076	6,940,622,589
Non-controlling interest	163,416,980	58,247,120
Profit/(loss) attributable	9,160,840,056	6,998,869,709
Other comprehensive income/(loss)	(14,240,677)	762
Total comprehensive income	9,146,599,379	6,998,870,471

Owners of the Company	8,983,182,399	6,940,623,351
Non-controlling interest	163,416,980	58,247,120
Total comprehensive income attributable	9,146,599,379	6,998,870,471

Earnings per share (EPS)	20.17	15.56

	Share capital	Share premium	Excess of issue price over face value of GDRs	Capital reserve on merger	Revaluation surplus	Unrealized gain/(loss)	Retained earnings	Equity attributable to owners of the Company	Non-controlling interests	Total
Balance as on 01 July 2025	4,461,120,890	5,269,474,690	1,689,636,958	294,950,950	1,133,870,432	18,148,958	40,239,934,223	53,107,137,101	3,977,498,766	57,084,635,867

Total comprehensive income:
Profit for the year	-	-	-	-	-	-	8,997,423,076	8,997,423,076	163,416,980	9,160,840,056
Other comprehensive income/(loss)	-	-	-	-	-	(14,240,677)	-	(14,240,677)	-	(14,240,677)
Transactions with the shareholders:
Cash dividend	-	-	-	-	-	-	-	-	(37,766,398)	(37,766,398)
Others:
Adjustment for depreciation on revalued assets	-	-	-	-	(3,935,254)	-	3,935,254	-	-	-
Adjustment for deferred tax on revalued assets	-	-	-	-	885,432	-	-	885,432	-	885,432
Balance as on 30 June 2026	4,461,120,890	5,269,474,690	1,689,636,958	294,950,950	1,130,820,610	3,908,281	49,241,292,553	62,091,204,932	4,103,149,348	66,194,354,280
Net asset value (NAV) per share 139.18

	Share capital	Share premium	Excess of issue price over face value of GDRs	Capital reserve on merger	Revaluation surplus	Unrealized gain/(loss)	Retained earnings	Equity attributable to owners of the Company	Non-controlling interests	Total
Balance as on 01 July 2024	4,461,120,890	5,269,474,690	1,689,636,958	294,950,950	1,137,305,789	18,148,196	35,079,327,271	47,949,964,744	3,952,938,136	51,902,902,880
Total comprehensive income:
Profit for the year	-	-	-	-	-	-	6,940,622,589	6,940,622,589	58,247,120	6,998,869,709
Other comprehensive income/(loss)	-	-	-	-	-	762	-	762	-	762
Transactions with the shareholders:
Cash dividend	-						(1,784,448,356)	(1,784,448,356)	(33,686,490)	(1,818,134,846)
Others:
Adjustment for depreciation on revalued assets	-	-	-	-	(4,432,719)	-	4,432,719	-	-	-
Adjustment for deferred tax on revalued assets	-	-	-	-	997,362	-	-	997,362	-	997,362
Balance as on 30 June 2025	4,461,120,890	5,269,474,690	1,689,636,958	294,950,950	1,133,870,432	18,148,958	40,239,934,223	53,107,137,101	3,977,498,766	57,084,635,867
Net asset value (NAV) per share 119.04

	30 June 2026	Amount in Taka 30 June 2025
Cash flows from operating activities:

Cash receipts from customers and others	56,660,083,852	49,891,648,809
Cash paid to suppliers and employees	(44,249,161,693)	(39,742,461,113)
Cash generated from operations	12,410,922,159	10,149,187,696

Interest paid	(652,368,635)	(976,729,205)
Interest received	298,941,277	19,922,699
Income tax paid	(2,542,680,987)	(1,969,795,120)
Net cash generated from operating activities	9,514,813,814	7,222,586,070

Cash flows from investing activities:
Acquisition of property, plant and equipment	(3,812,442,309)	(2,781,313,389)
Intangible assets	(233,252,022)	(247,936,908)
Disposal of property, plant and equipment	11,223,226	60,327,928
Disposal of intangible assets	18,255,000	-
Dividend received	1,088,746	974,510
Short term investment	(50,000,000)	(700,000,000)
Net cash used in investing activities	(4,065,127,359)	(3,667,947,859)

Cash flows from financing activities:

Net increase/(decrease) in long term borrowings	(559,616,178)	(152,518,998)
Net increase/(decrease) in short term borrowings	278,073,364	(971,266,326)
Dividend paid	(202,084,029)	(1,603,086,311)
Net cash from/(used in) financing activities	(483,626,843)	(2,726,871,635)
Increase/(decrease) in cash and cash equivalents	4,966,059,612	827,766,576
Opening cash and cash equivalents	1,700,096,960	854,105,649
Effect of exchange rate changes on cash and cash equivalents	1,855,907	18,224,735
Closing cash and cash equivalents	6,668,012,479	1,700,096,960

Net operating cash flows per share	21.33	16.19

Results for the year ended 30 June 2026

Summary by AI BETAClose X

Companies

UK 100

Latest directors dealings

Summary by AI ^BETAClose X